(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-CD47 E MÉTODOS DE USO

Em AnáliseInvention PatentPCT · CN2023143103

Application data

Number

112025013151

Type

Invention Patent

Filing

12/29/2023

Publication

03/24/2026

PCT

CN2023143103

Progress at the INPI

Examination not yet requested
  1. Filing12/29/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 12/29/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/29/2026(126 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/24/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SHANGHAI HENLIUS BIOLOGICS CO., LTD.

CN

SHANGHAI HENLIUS BIOPHARMACEUTICAL CO., LTD.

CN

SHANGHAI HENLIUS BIOTECH, INC.

CN

See this company's full portfolio

Inventors

B. T. (pessoa física)

CN

X. W. (pessoa física)

CN

Technical data

Priority claims

CN

PCT/CN2022/143504 · 12/29/2022

Abstract

A presente divulgação refere-se a anticorpos e derivados de anticorpos que se ligam ao CD47 (também conhecidos como IAP, MER6 e OA3) e métodos de uso dos mesmos. Em certas modalidades, um anticorpo anti-CD47 ou derivado de anticorpo divulgado neste documento exibe ligação reduzida a um eritrócito.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/24/2026

RPI 2881

Alteração de dados cadastrais

#1.1

07/22/2025

RPI 2846

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.